The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial
Journal Title: BMC Women's Health - Year 2012, Vol 12, Issue
Abstract
In in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of pregnancy. The implantation rate per embryo transferred is only 30%. Studies have shown that minor intrauterine abnormalities can be found in 11–45% of infertile women with a normal transvaginal sonography or hysterosalpingography. Two randomised controlled trials have indicated that detection and treatment of these abnormalities by office hysteroscopy after two failed IVF cycles leads to a 9–13% increase in pregnancy rate. Therefore, screening of all infertile women for intracavitary pathology prior to the start of IVF/ICSI is increasingly advocated. In absence of a scientific basis for such a policy, this study will assess the effects and costs of screening for and treatment of unsuspected intrauterine abnormalities by routine office hysteroscopy, with or without saline infusion sonography (SIS), prior to a first IVF/ICSI cycle.
Authors and Affiliations
Janine G Smit, Jenneke C Kasius, Marinus JC Eijkemans, Carolien AM Koks, Ron Van Golde, Jurjen GE Oosterhuis, Annemiek W Nap, Gabrielle J Scheffer, Petra AP Manger, Annemiek Hoek, Mesrure Kaplan, Dick BC Schoot, Arne M van Heusden, Walter KH Kuchenbecker, Denise AM Perquin, Kathrin Fleischer, Eugenie M Kaaijk, Alexander Sluijmer, Jaap Friederich, Joop SE Laven, Marcel van Hooff, Leonie A Louwe, Janet Kwee, Jantien J Boomgaard, Corry H de Koning, Ineke CAH Janssen, Femke Mol, Ben WJ Mol, Helen L Torrance, Frank JM Broekmans
Keywords
Related Articles
- EP ID EP679505
- DOI 10.1186/1472-6874-12-22
- Views 50
- Downloads 0
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial
Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between...
“Voices of Fear and Safety” Women’s ambivalence towards breast cancer and breast health: a qualitative study from Jordan
Breast cancer is the leading cause of cancer mortality among Jordanian women. Breast malignancies are detected at late stages as a result of deferred breast health-seeking behaviour. The aim of this study was to explore...
Comparing the analgesic effect of heat patch containing iron chip and ibuprofen for primary dysmenorrhea: a randomized controlled trial
Primary dysmenorrhea is a common and sometimes disabling condition. In recent years, some studies aimed to improve the treatment of dysmenorrhea, and therefore, introduced several therapeutic measures. This study was des...
Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women
In 2009 the Uterine Bleeding and Pain Women's Research Study (UBP-WRS) was conducted interviewing 21,479 women across 8 countries in order to gain patient-based prevalence data on uterine pain and bleeding indications an...
Mammography-based screening program: preliminary results from a first 2-year round in a Brazilian region using mobile and fixed units
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer deaths among women worldwide. The use of mobile mammography units to offer screening to women living in remote areas is a rational str...